Reuters logo
BRIEF-Gene Techno Science commences phase III clinical trial for biosimilars in ophthalmology
November 9, 2017 / 4:01 AM / a month ago

BRIEF-Gene Techno Science commences phase III clinical trial for biosimilars in ophthalmology

Nov 9 (Reuters) - Gene Techno Science Co Ltd

* Says it commenced the phase III clinical trial for biosimilars in ophthalmology, which is a joint work between the co and Senju Pharmaceutical Co Ltd

Source text in Japanese: goo.gl/jbvWVM

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below